ARTICLE | Clinical News
Benzhydrocodone/acetaminophen regulatory update
January 25, 2016 8:00 AM UTC
KemPharm submitted an NDA to FDA and requested Priority Review for KP201/APAP to treat acute pain. The product is an abuse-deterrent formulation of benzhydrocodone, a hydrocodone prodrug, and acetamin...